High MDR1 expression in RA is associated with increased MMP-3 levels and use of bDMARDs: potential independence of JAK inhibitors from MDR1.

Onoi Y, Hayashi S, Kikuchi K, Tsubosaka M, Kamenaga T, Kuroda Y, Nakano N, Tsumiyama K, Matsumoto T, Kuroda R, Matsubara T

Open source

DOI: 10.1093/rheumatology/keaf622
Published: 2026 Feb 4
Container: Rheumatology (Oxford, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keaf622,
  title = {High MDR1 expression in RA is associated with increased MMP-3 levels and use of bDMARDs: potential independence of JAK inhibitors from MDR1.},
  author = {Onoi Y and Hayashi S and Kikuchi K and Tsubosaka M and Kamenaga T and Kuroda Y and Nakano N and Tsumiyama K and Matsumoto T and Kuroda R and Matsubara T},
  year = {2026},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/keaf622},
  url = {https://doi.org/10.1093/rheumatology/keaf622}
}

RIS

TY  - JOUR
TI  - High MDR1 expression in RA is associated with increased MMP-3 levels and use of bDMARDs: potential independence of JAK inhibitors from MDR1.
AU  - Onoi Y
AU  - Hayashi S
AU  - Kikuchi K
AU  - Tsubosaka M
AU  - Kamenaga T
AU  - Kuroda Y
AU  - Nakano N
AU  - Tsumiyama K
AU  - Matsumoto T
AU  - Kuroda R
AU  - Matsubara T
PY  - 2026
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/keaf622
UR  - https://doi.org/10.1093/rheumatology/keaf622
ER  -

APA

Y, O., S, H., K, K., M, T., T, K., Y, K., N, N., K, T., T, M., R, K., & T, M. (2026). High MDR1 expression in RA is associated with increased MMP-3 levels and use of bDMARDs: potential independence of JAK inhibitors from MDR1.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keaf622

Source records

pubmed · retrieved 2026-09-26T10:44:07.737Z